ReviewThe European respiratory journal2022
Asthma management in low and middle income countries: case for change.
Review in The European respiratory journal, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT06652542 (Asthma Exacerbations & Respiratory Management), which is not on this map. Cited by 78 papers, 3 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Asthma Exacerbations & Respiratory Management: An International Online Survey Endorsed by the International Association of Non-invasive Ventilation & International College of Experts
Who cites it
78 citing papers in PubMed, 3 syntheses or guidelines pooled it, 150 citations in OpenAlex.
- Prevalence of chronic respiratory disease using case-finding tools in adults living with noncommunicable disease in low- and middle-income countries: a systematic review.BMC pulmonary medicine · 2025Pooled it
- Global research trends in obesity-related asthma (2004-2023): a bibliometric analysis.Frontiers in nutrition · 2025Pooled it
- Combined Lifestyle Interventions in the Prevention and Management of Asthma and COPD: A Systematic Review.Nutrients · 2024Pooled it
- Comparison of ICS dose reduction vs. montelukast discontinuation for step-down therapy in well-controlled asthma: a pilot randomized controlled trial.BMC pulmonary medicine · 2025Trial
- Effectiveness and implementation of a multi-faceted intervention to facilitate adoption of asthma self-management practices in Peruvian children and adolescents: a hybrid type 2 individually randomized controlled trial.Frontiers in public health · 2025Trial
- Child characteristics, household, and home environmental factors associated with eczema: a cross-sectional study.European journal of pediatrics · 2026Article
- Global Asthma Disparities: Deciphering the Multifaceted Environmental Exposome Between Eastern and Western Populations.Clinical reviews in allergy & immunology · 2026Review
- Asthma Care in Resource-Limited Settings: Closing the Treatment Gap Through Access, Innovation, and Action.Cureus · 2026Article
- Global Asthma Burden due to Attributable Risk Factors, 1990-2021, and Forecast to 2050: A Systematic Analysis of the Global Burden of Disease Study 2021.NPJ primary care respiratory medicine · 2026Article
- Comparative Clinical Presentation of Bronchial Asthma in Adults and Children in North India.Cureus · 2026Article
- Challenges in translating GINA asthma recommendations into practice: a qualitative study of healthcare professionals in Jordan.BMJ open · 2026Article
- Peak flow meter is a sensitive test for assessing airflow limitation in patients with respiratory symptoms suggestive of asthma in primary health care in Brazil.BMC primary care · 2026Article
- Age-sex differences in the global burden of asthma and risk factors, 1990-2021: results from the global burden of disease study 2021.BMC pulmonary medicine · 2026Article
- Costs of Single Maintenance and Reliever Therapy vs Traditional Therapy for Asthma.JAMA network open · 2026Article
- Vitamin D Deficiency in Children with Asthma and Overweight/Obesity in Qatar.Journal of asthma and allergy · 2026Article
- Associations between childhood adverse experiences and medication adherence in asthma patients: a dual variable-centered and person-centered analysis of attachment security and mentalization.Frontiers in psychiatry · 2026Article
- Cost-effectiveness of as-needed budesonide-formoterol in adults with mild asthma: the Novel START trial.ERJ open research · 2026Article
- Multifaceted mechanistic exploration ofFrontiers in cell and developmental biology · 2026Article
- In-Hospital Outcomes and Mortality of Pediatric Asthma Exacerbations in Thailand: A Nationwide Study (2015-2022).Journal of asthma and allergy · 2026Article
- Prevalence of asthma and the premature mortality in Eastern sub-Saharan Africa, from 1990 to 2023.SAGE open medicine · 2026Article
18 more citing papers are in PubMed but not listed here.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors at 4 institutions in 4 countries.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Asthma is the most common noncommunicable disease in children, and among the most common in adults. The great majority of people with asthma live in low and middle income countries (LMICs), which have disproportionately high asthma-related morbidity and mortality. Essential inhaled medications, particularly those containing inhaled corticosteroids (ICS), are often unavailable or unaffordable, and this explains much of the global burden of preventable asthma morbidity and mortality. Guidelines developed for LMICs are generally based on the outdated assumption that patients with asthma symptoms <1-3 times per week do not need (or benefit from) ICS. Even when ICS are prescribed, many patients manage their asthma with oral or inhaled short-acting β
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.